This link brings you to a 3rd Party Website, over which Standard Chartered Bank Malaysia Berhad has no control ("3rd Party Website"). Use of the 3rd Party Website will be entirely at your own risk, and subject to the terms of the 3rd Party Website, including those relating to confidentiality, data privacy and security.

Standard Chartered Bank Malaysia Berhad makes no warranties, representations or undertakings about and does not endorse, recommend or approve the contents of the 3rd Party Website.

In addition to the terms stated in Standard Chartered Bank Malaysia Berhad's Important Legal Notices, Standard Chartered Bank Malaysia Berhad shall have no responsibility or liability in connection with the content of or the consequences of accessing the 3rd Party Website, including any virus arising from or system failure associated with the 3rd Party Website.


A race between the virus & the vaccine

A race between the virus & the vaccine

A race between the virus & the vaccine

Title A race between the virus & the vaccine
Webinar Details There is a resurgence of Covid-19 infections globally, notably in the U.S, UK, and China while U.S and European equity indexes continue to trend higher.

Are we closer to the end of the pandemic or are we due for a market correction?

Will economic recovery hit a speed bump?

Host Ng Shin Seong

Head, Investment Strategy & Advisory

Standard Chartered Bank

Speaker(s) Martin Connaghan

Investment Director

Aberdeen Standard Investments

Registration Link https://primetime.bluejeans.com/a2m/register/fzkcfhys
Post event

Key Takeaways

Thank you for joining our session with Martin Connaghan, Investment Director of Aberdeen Islamic World Equity Fund at our webinar held last Saturday.


This fund has done exceptionally well year-to-date, +24.08% as compared to +21.38%* in the S&P 500 index.


*Source: Morningstar: Fund performance in MYR NAV-to-NAV with dividends reinvested as at30 Aug 2021. S&P 500 performance in USD.


Martin shared his views on why it is now a race between the virus and the vaccine, which sectors and stocks he favors and his opinion on the Chinese stock markets.


Here are some highlights of the webinar:


1. S&P 500 has hit all-time highs about 50 times in 2021 and many investors are cautious that the rally may not persist. If history is of any lesson (i.e. 1954 and 1995), there could still be more room for stock prices to trend higher. Company earnings growth have been very strong in 2021 and the trend will persist well into 2022, thus supporting the stock market rally.


2. Many countries are adapting to ‘Live with Covid”. Economic activities are reinstated even as Covid cases continue to rise due to new cases have tended to be mild & asymptomatic. The reopening of economies will provide further boost to company earnings along with fiscal and monetary policy support.


3. The fund is overweight in healthcare and industrials, sectors that are benefiting from latest consumer trends of taking care of themselves and infrastructure and capex spending from government and companies.


Lastly, Martin opined that the rapid sell down in Chinese stocks have made some companies to be attractive for investment.


You can now invest into Aberdeen Islamic World Equity via SmartDirect today.

A race between the virus & the vaccine

Rapid sell down in Chinese stocks have made some companies to be attractive for investment.


This live webinar is for general information only and it does not constitute an offer, recommendation or solicitation of an offer to enter into a transaction or adopt any hedging, trading or investment strategy, nor does it constitute any prediction of likely future movements in rates or prices or any representation that any such future movements will not exceed those shown in any illustration. The information presented in this live webinar is for general evaluation only and has not been prepared to be suitable for any particular person or class of persons. It has been prepared without regards to the specific investment objectives, financial situation or particular needs of any person. You should seek advice from a financial adviser on the suitability of a product for you, taking into account these factors before making a commitment to purchase the product. In the event that you choose not to seek advice from a licensed or an exempt financial adviser, you should carefully consider whether the product is suitable for you. Past performance is not indicative of future results and no representation or warranty is made regarding future performance. You are fully responsible for your investment decision, including whether the product or service described (if any) during the live webinar session is suitable for you. The products involved are principal at risk and you may lose all or part of your original investment amount. Standard Chartered Bank Malaysia Berhad (“Bank”) will not accept any responsibility or liability of any kind, with respect to the accuracy or completeness of the information discussed during the live webinar session. The Bank accepts no liability for any of the views, comments or opinions made by the external speaker(s) at the session. The Bank makes no representation or warranty of any kind, express, implied or statutory regarding this session or any information contained or referred to on this session.